|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 225 studies with search of: | Open Studies | "Carcinoma, Hepatocellular" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
|
||||
| 2 | Recruiting |
A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma
|
||||
| 3 | Not yet recruiting |
Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
|
||||
| 4 | Recruiting |
Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
|
||||
| 5 | Recruiting |
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
|
||||
| 6 | Recruiting |
Trial for Hepatocellular Carcinoma Related Viral Hepatitis Adjuvant Treatment
|
||||
| 7 | Recruiting |
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
|
||||
| 8 | Recruiting |
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
|
||||
| 9 | Recruiting |
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma
|
||||
| 10 | Recruiting |
Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
|
||||
| 11 | Recruiting |
Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
|
||||
| 12 | Recruiting |
Dose Escalation Study for Primary Hepatocellular Carcinoma
|
||||
| 13 | Recruiting |
Dose Escalation Study Using Respiratory Gated Proton Beam Radiotherapy for Hepatocellular Carcinoma
|
||||
| 14 | Recruiting |
PII Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
|
||||
| 15 | Recruiting |
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas
|
||||
| 16 | Recruiting |
Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma
|
||||
| 17 | Recruiting |
Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma
|
||||
| 18 | Recruiting |
Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
|
||||
| 19 | Recruiting |
BIBF 1120 in Hepatocellular Carcinoma Patients
|
||||
| 20 | Recruiting |
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|